vs
NICE Ltd.(NICE)与West Pharmaceutical Services(WST)财务数据对比。点击上方公司名可切换其他公司
NICE Ltd.的季度营收约是West Pharmaceutical Services的1.6倍($1.3B vs $805.0M),NICE Ltd.净利率更高(16.8% vs 16.4%,领先0.4%),NICE Ltd.自由现金流更多($407.2M vs $175.0M)
NICE Ltd.是一家美国科技企业,专注于客户关系管理软件、人工智能技术、数字化交互与劳动力参与管理解决方案的研发,旗下产品可帮助各行业企业优化运营效率,提升客户服务体验。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商,1923年成立,总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件,曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
NICE vs WST — 直观对比
营收规模更大
NICE
是对方的1.6倍
$805.0M
净利率更高
NICE
高出0.4%
16.4%
自由现金流更多
NICE
多$232.2M
$175.0M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.3B | $805.0M |
| 净利润 | $222.2M | $132.1M |
| 毛利率 | 66.2% | 37.8% |
| 营业利润率 | 18.9% | 19.5% |
| 净利率 | 16.8% | 16.4% |
| 营收同比 | — | 7.5% |
| 净利润同比 | — | 1.5% |
| 每股收益(稀释后) | — | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
NICE
WST
| Q4 25 | — | $805.0M | ||
| Q3 25 | — | $804.6M | ||
| Q2 25 | $1.3B | $766.5M | ||
| Q1 25 | — | $698.0M | ||
| Q4 24 | — | $748.8M | ||
| Q3 24 | — | $746.9M | ||
| Q2 24 | $1.2B | $702.1M | ||
| Q1 24 | — | $695.4M |
净利润
NICE
WST
| Q4 25 | — | $132.1M | ||
| Q3 25 | — | $140.0M | ||
| Q2 25 | $222.2M | $131.8M | ||
| Q1 25 | — | $89.8M | ||
| Q4 24 | — | $130.1M | ||
| Q3 24 | — | $136.0M | ||
| Q2 24 | $164.3M | $111.3M | ||
| Q1 24 | — | $115.3M |
毛利率
NICE
WST
| Q4 25 | — | 37.8% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | 66.2% | 35.7% | ||
| Q1 25 | — | 33.2% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 35.4% | ||
| Q2 24 | 67.4% | 32.8% | ||
| Q1 24 | — | 33.1% |
营业利润率
NICE
WST
| Q4 25 | — | 19.5% | ||
| Q3 25 | — | 20.8% | ||
| Q2 25 | 18.9% | 20.1% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 21.6% | ||
| Q2 24 | 17.3% | 18.0% | ||
| Q1 24 | — | 17.7% |
净利率
NICE
WST
| Q4 25 | — | 16.4% | ||
| Q3 25 | — | 17.4% | ||
| Q2 25 | 16.8% | 17.2% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | 17.4% | ||
| Q3 24 | — | 18.2% | ||
| Q2 24 | 14.2% | 15.9% | ||
| Q1 24 | — | 16.6% |
每股收益(稀释后)
NICE
WST
| Q4 25 | — | $1.82 | ||
| Q3 25 | — | $1.92 | ||
| Q2 25 | — | $1.82 | ||
| Q1 25 | — | $1.23 | ||
| Q4 24 | — | $1.78 | ||
| Q3 24 | — | $1.85 | ||
| Q2 24 | — | $1.51 | ||
| Q1 24 | — | $1.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $481.7M | $791.3M |
| 总债务越低越好 | — | $202.8M |
| 股东权益账面价值 | $3.6B | $3.2B |
| 总资产 | $5.3B | $4.3B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势,按日历期对齐
现金及短期投资
NICE
WST
| Q4 25 | — | $791.3M | ||
| Q3 25 | — | $628.5M | ||
| Q2 25 | $481.7M | $509.7M | ||
| Q1 25 | — | $404.2M | ||
| Q4 24 | — | $484.6M | ||
| Q3 24 | — | $490.9M | ||
| Q2 24 | $511.8M | $446.2M | ||
| Q1 24 | — | $601.8M |
总债务
NICE
WST
| Q4 25 | — | $202.8M | ||
| Q3 25 | — | $202.7M | ||
| Q2 25 | — | $202.6M | ||
| Q1 25 | — | $202.6M | ||
| Q4 24 | — | $202.6M | ||
| Q3 24 | — | $202.6M | ||
| Q2 24 | — | $205.8M | ||
| Q1 24 | — | $206.2M |
股东权益
NICE
WST
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | $3.6B | $2.9B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $3.4B | $2.6B | ||
| Q1 24 | — | $2.7B |
总资产
NICE
WST
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | $5.3B | $4.0B | ||
| Q1 25 | — | $3.6B | ||
| Q4 24 | — | $3.6B | ||
| Q3 24 | — | $3.7B | ||
| Q2 24 | $5.1B | $3.5B | ||
| Q1 24 | — | $3.6B |
负债/权益比
NICE
WST
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $424.2M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $407.2M | $175.0M |
| 自由现金流率自由现金流/营收 | 30.8% | 21.7% |
| 资本支出强度资本支出/营收 | 1.3% | 9.5% |
| 现金转化率经营现金流/净利润 | 1.91× | 1.90× |
| 过去12个月自由现金流最近4个季度 | — | $468.9M |
8季度趋势,按日历期对齐
经营现金流
NICE
WST
| Q4 25 | — | $251.1M | ||
| Q3 25 | — | $197.2M | ||
| Q2 25 | $424.2M | $177.1M | ||
| Q1 25 | — | $129.4M | ||
| Q4 24 | — | $190.1M | ||
| Q3 24 | — | $180.1M | ||
| Q2 24 | $260.3M | $165.0M | ||
| Q1 24 | — | $118.2M |
自由现金流
NICE
WST
| Q4 25 | — | $175.0M | ||
| Q3 25 | — | $133.9M | ||
| Q2 25 | $407.2M | $101.9M | ||
| Q1 25 | — | $58.1M | ||
| Q4 24 | — | $85.2M | ||
| Q3 24 | — | $98.8M | ||
| Q2 24 | $242.7M | $64.8M | ||
| Q1 24 | — | $27.6M |
自由现金流率
NICE
WST
| Q4 25 | — | 21.7% | ||
| Q3 25 | — | 16.6% | ||
| Q2 25 | 30.8% | 13.3% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | 21.1% | 9.2% | ||
| Q1 24 | — | 4.0% |
资本支出强度
NICE
WST
| Q4 25 | — | 9.5% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | 1.3% | 9.8% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | 1.5% | 14.3% | ||
| Q1 24 | — | 13.0% |
现金转化率
NICE
WST
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | 1.91× | 1.34× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | 1.58× | 1.48× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NICE
| Cloud | $950.1M | 72% |
| Services | $296.5M | 22% |
| Product | $77.1M | 6% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |